シリアルブロック面と集値イオンビームスキャン電子顕微鏡を用いた標的研究

Executive Industry Relevance

This protocol enables biopharma R&D teams to perform targeted 3D ultrastructural analysis of rare cellular events within complex tissues, supporting mechanistic de-risking in early discovery. By combining SBF-SEM for contextual overview and FIB-SEM for high-resolution detail, it improves predictive confidence in target validation and pathway elucidation. The workflow enhances translational continuity from discovery through preclinical stages by providing reproducible, quantitative structural data.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses through 3D visualization of subcellular architecture in disease-relevant systems.
• Operational Value: Supports biological de-risking by clarifying spatial relationships between cells and intracellular structures prior to lead identification.

Screening & Assay Development

• Scientific Value: Prepares validated biological systems for downstream assay development by establishing baseline ultrastructural phenotypes.
• Operational Value: Enhances assay standardization and reproducibility through correlative imaging workflows that reduce variability in sample preparation.

Translational & Preclinical Research

• Scientific Value: Provides disease-relevant structural insights that align with translational biomarker discovery and mechanistic de-risking.
• Operational Value: Enables risk-adjusted advancement decisions by delivering quantitative, high-resolution data for preclinical model validation.

Pipeline & Workflow Integration

The method integrates into the discovery continuum by supporting hypothesis testing in early biology, enabling assay readiness through standardized preparation, and delivering quantitative readouts for cross-functional analytics.

• Discovery Biology: Facilitates target validation by revealing spatial orientations of cells and intracellular connections critical for pathway clarification.
• Screening: Ensures assay readiness via microwave-assisted processing that improves reproducibility and scalability of sample preparation.
• Analytics: Generates aligned 3D TIFF datasets that allow teams to compare structural conditions and track ROI-specific changes over time.
• Translational Research: Supports preclinical continuity by providing correlative SBF-SEM and FIB-SEM data that bridge discovery-scale context with subcellular detail.
• Enterprise Reuse: Establishes a reusable imaging capability for targeted ROI analysis across multiple projects and model systems.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence in target validation through reduction of mechanistic ambiguity in 3D ultrastructure.
• Operational Value: Standardization and reproducibility via microwave-assisted processing and correlative workflow.
• Strategic Value: Improved go/no-go decisions by enabling capital-efficient, data-driven target prioritization.
• Portfolio Impact: Risk-adjusted advancement decisions supported by quantitative, reproducible structural outputs.

Implementation Considerations

• Requires expertise in electron microscopy techniques including SBF-SEM and FIB-SEM operation and sample preparation.
• Dependent on access to integrated SEM platforms with ultramicrotome and focused ion beam capabilities.
• Necessitates cross-team standardization of fixation, staining, and infiltration protocols for reproducible results.
• Involves adaptation considerations when applying the workflow to diverse biological models beyond plant systems.
• Limited by the labor-intensive nature of sample preparation despite microwave-assisted time reduction.

Biopharma FAQs